Search International and National Patent Collections

1. (WO2018060373) DUAL-ACTION ELAFIBRANOR METFORMIN SALT FOR TREATING OBESITY ASSOCIATED WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND HYPERTRIGLYCERIDAEMIA

Pub. No.:    WO/2018/060373    International Application No.:    PCT/EP2017/074703
Publication Date: Fri Apr 06 01:59:59 CEST 2018 International Filing Date: Fri Sep 29 01:59:59 CEST 2017
IPC: A61K 31/155
A61K 31/192
C07C 279/26
C07C 323/62
A61K 9/00
A61P 1/16
A61P 3/06
A61P 3/10
A61P 3/04
A61P 9/00
Applicants: NASHPHARM
Inventors: LARUELLE, Claude
BONNAFOUS, Ludovic
Title: DUAL-ACTION ELAFIBRANOR METFORMIN SALT FOR TREATING OBESITY ASSOCIATED WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND HYPERTRIGLYCERIDAEMIA
Abstract:
The present invention relates to drugs derived from elafibranor. It relates more specifically to a composition comprising at least one active ingredient, characterised in that at least one active ingredient comprises an elafibranor metformin salt. The present invention also relates to a dual-action elafibranor derivative for treating obesity associated with non-alcoholic steatohepatitis (NASH) and hypertriglyceridaemia.